Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.6B | 6.0B | 6.1B | 6.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | 649M |
| Other operating expenses | 829M | 1.1B | 712M | 192M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 3.9B | 2.0B | 3.5B | 3.7B |
| Tax provision | 1.1B | 7M | 1.0B | 1.0B |
| Net income | 2.8B | 2.0B | 2.5B | 2.7B |
| Basic EPS | 1.8 | 1.0 | 1.6 | 1.6 |
| Diluted EPS | 1.8 | 1.0 | 1.6 | 1.6 |
| Basic average shares | 1.6B | 1.9B | 1.6B | 1.6B |
| Diluted average shares | 1.6B | 1.9B | 1.6B | 1.6B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -19M | -34M | -7M | -7M |
| Preferred stock dividends | — | — | — | — |